Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

Cited by (1,001)

Items 101–200 of 1,001

  1. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
    Yumei Ye, Mandeep Bajaj, Hsiu‐Chiung Yang, Jose R. Perez-Polo, Yochai Birnbaum · 2017 · Cardiovascular Drugs and Therapy
  2. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
    Lieselotte Vande Walle, Mohamed Lamkanfi · 2023 · Nature Reviews Drug Discovery
  3. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism
    Xingyong Wan, Chengfu Xu, Yiming Lin, Chao Lü, Dejian Li, Jianzhong Sang, Haijian He, Xiao Liu, Youming Li, Chaohui Yu · 2015 · Journal of Hepatology
  4. Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
    Eiji Yoshihara, So Masaki, Yoshiyuki Matsuo, Zhe Chen, Hai Tian, Junji Yodoi · 2014 · Frontiers in Immunology
  5. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
    Tiantian Tang, Xueting Lang, Cong‐Fei Xu, Xiaqiong Wang, Tao Gong, Yanqing Yang, Jun Cui, Li Bai, Jun Wang, Wei Jiang et al. · 2017 · Nature Communications
  6. Islet inflammation in type 2 diabetes and physiology
    Kosei Eguchi, Ryozo Nagai · 2017 · Journal of Clinical Investigation
  7. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
    Donath, Marc Y., Dalmas, Élise, Sauter, Nadine S., Böni-Schnetzler, Marianne · 2013 · Cell Metabolism
  8. Type 2 diabetes as a protein misfolding disease
    Abhisek Mukherjee, Diego Morales‐Scheihing, Peter C. Butler, Claudio A. Soto · 2015 · Trends in Molecular Medicine
  9. Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages
    Kelly, Beth, Tannahill, Gillian M., Murphy, Michael P., O'Neill, Luke A.J. · 2015 · Journal of Biological Chemistry
  10. Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
    Jamison J. Grailer, Bethany A. Canning, Miriam Kalbitz, Mikel D. Haggadone, Rasika Dhond, Anuska V. Andjelkovic, Firas S. Zetoune, Peter A. Ward · 2014 · The Journal of Immunology
  11. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
    Brendan M. Everett, Marc Yves Donath, Aruna D. Pradhan, Tom Y. Thuren, Prem S Pais, José Carlos Nicolau, Robert J. Glynn, Peter Libby, Paul M. Ridker · 2018 · Journal of the American College of Cardiology
  12. Pyroptosis, metabolism, and tumor immune microenvironment
    Tiantian Du, Jie Gao, Peilong Li, Yunshan Wang, Qiuchen Qi, Xiaoyan Liu, Juan Li, Chuanxin Wang, Lutao Du · 2021 · Clinical and Translational Medicine
  13. Functions of NOD-Like Receptors in Human Diseases
    Yifei Zhong, Anna Eva Kinio, Maya Saleh · 2013 · Frontiers in Immunology
  14. Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis
    Stefan Freigang, Franziska Ampenberger, Adrienne Weiss, Thirumala‐Devi Kanneganti, Yoichiro Iwakura, Martin Hersberger, Manfred Köpf · 2013 · Nature Immunology
  15. Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases
    Antero Salminen, Johanna O. Ojala, Kai Kaarniranta, Anu Kauppinen · 2012 · Cellular and Molecular Life Sciences
  16. Nanoparticle-Based Vaccines Against Respiratory Viruses
    Al Halifa Soultan, Laurie Gauthier, Dominic Arpin, Steve Bourgault, Denis Archambault · 2019 · Frontiers in Immunology
  17. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
    Hadi Khodabandehloo, Sattar Gorgani‐Firuzjaee, Ghodratollah Panahi, Reza Meshkani · 2015 · Translational research
  18. NLRP3 at the interface of metabolism and inflammation
    Moritz Haneklaus, Luke A.J. O'Neill · 2015 · Immunological Reviews
  19. The Inflammasomes and Autoinflammatory Syndromes
    Lori Broderick, Dominic De Nardo, Bernardo S. Franklin, Hal M. Hoffman, Eicke Latz · 2014 · Annual Review of Pathology Mechanisms of Disease
  20. Anakinra Therapy for Non-cancer Inflammatory Diseases
    Giulio Cavalli, Charles Anthony Dinarello · 2018 · Frontiers in Pharmacology
  21. Mitochondria: Sovereign of inflammation?
    Jürg Tschopp · 2011 · European Journal of Immunology
  22. Focus on the Role of NLRP3 Inflammasome in Diseases
    Roberta Fusco, Rosalba Siracusa, Tiziana Genovese, Salvatore Cuzzocrea, Rosanna Di Paola · 2020 · International Journal of Molecular Sciences
  23. Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects.
    Chen Xia, Z. Zeng, Bin Fang, Min Tao, Chenhui Gu, Lin Zheng, Yi-Yun Wang, Yiling Shi, Chen Fang, Sheng Mei et al. · 2019 · Free Radical Biology & Medicine
  24. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation
    Peruzzotti-Jametti, Luca, Bernstock, Joshua D., Vicario, Nunzio, Costa, Ana S.H., Kwok, Chee Keong, Leonardi, Tommaso, Booty, Lee M., Bicci, Iacopo, Balzarotti, Beatrice, Volpe, Giulio et al. · 2018 · Cell Stem Cell
  25. DAMPs as mediators of sterile inflammation in aging-related pathologies
    Feldman, Noa, Rotter-Maskowitz, Aviva, Okun, Eitan · 2015 · Ageing Research Reviews
  26. NLR functions beyond pathogen recognition
    Thomas A. Kufer, Philippe Jean Sansonetti · 2011 · Nature Immunology
  27. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
    Zewinger, Stephen, Reiser, Jochen, Jankowski, Vera, Alansary, Dalia, Hahm, Eunsil, Triem, Sarah, Klug, Mira, Schunk, Stefan J., Schmit, David, Kramann, Rafael et al. · 2020 · Nature Immunology
  28. Sensing damage by the NLRP3 inflammasome
    Leemans, Jaklien C., Cassel, Suzanne L., Sutterwala, Fayyaz S. · 2011 · Immunological Reviews
  29. Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity
    Orla M. Finucane, Claire L. Lyons, Aoife Marie Murphy, Clare M. Reynolds, Rut W. Klinger, Niamh P. Healy, Aoife A. Cooke, Rebecca C. Coll, Liam McAllan, Kanishka N. Nilaweera et al. · 2015 · Diabetes
  30. Interleukin-1 function and role in rheumatic disease
    Georg Andreas Schett, Jean‐Michel Dayer, Bernhard Manger · 2015 · Nature Reviews Rheumatology
  31. 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome
    Yuan He, Saranyaraajan Varadarajan, Raúl Muñoz-Planillo, Aaron Burberry, Yuumi Nakamura, Gabriel Núñez · 2013 · Journal of Biological Chemistry
  32. The Inflammasome Puts Obesity in the Danger Zone
    Rinke Stienstra, Cees J. Tack, Thirumala‐Devi Kanneganti, Leo A. B. Joosten, Mihai Gheorghe Netea · 2012 · Cell Metabolism
  33. Islet amyloid polypeptide: structure, function, and pathophysiology
    Akter, Rehana, Cao, Ping, Noor, Harris, Ridgway, Zachary, Tu, Ling-Hsien, Wang, Hui, Wong, Amy G., Zhang, Xiaoxue, Abedini, Andisheh, Schmidt, Ann Marie et al. · 2016 · Journal of Diabetes Research
  34. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways
    Huahong Yang, Hongming Lv, Haijun Li, Xinxin Ci, Liping Peng · 2019 · Cell Communication and Signaling
  35. Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
    Ridker, Paul M · 2019 · Circulation Research
  36. Expansion of Islet-Resident Macrophages Leads to Inflammation Affecting β Cell Proliferation and Function in Obesity
    Wei Ying, Yun Sok Lee, Yi Wei Dong, Jason S. Seidman, Meixiang Yang, Roi Isaac, Jong Bae Seo, Bi-Huei Yang, Joshua Wollam, Matthew Riopel et al. · 2018 · Cell Metabolism
  37. Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation
    Orlowski, Gregory M, Colbert, Jeff D, Sharma, Shruti, Bogyo, Matthew, Robertson, Stephanie A, Rock, Kenneth L · 2015 · The Journal of Immunology
  38. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome
    Busillo, John M., Azzam, Kathleen M., Cidlowski, John A. · 2011 · Journal of Biological Chemistry
  39. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus
    Christensen, Dan P, Dahllöf, Mattias, Lundh, Morten, Rasmussen, Daniel N, Nielsen, Mette D, Billestrup, Nils, Grunnet, Lars G, Mandrup-Poulsen, Thomas · 2011 · Molecular Medicine
  40. Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
    Rena M. Pollack, Marc Yves Donath, Derek LeRoith, Gil Leibowitz · 2016 · Diabetes Care
  41. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming
    Xiuting Liu, Xin Zhang, Yang Ding, Wei Zhou, Lei Tao, Ping Lü, Yajing Wang, Rong Hu · 2016 · Antioxidants and Redox Signaling
  42. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations
    Leanne Marie Mortimer, France Moreau, Justin A. MacDonald, Kris Chadee · 2016 · Nature Immunology
  43. Nanoparticle-Based Delivery Systems for Vaccines
    Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee, Lalitkumar K. Vora · 2022 · Vaccines
  44. Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
    Sumaira Zia Hasnain, Johannes B. Prins, Michael A. McGuckin · 2015 · Journal of Molecular Endocrinology
  45. The NLRP3 Inflammasome in Alzheimer’s Disease
    Meng‐Shan Tan, Jin‐Tai Yu, Teng Jiang, Xi‐Chen Zhu, Lan Tan · 2013 · Molecular Neurobiology
  46. Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease
    Julie McAuley, Michelle D. Tate, Charley Mackenzie-Kludas, Anita A. Pinar, Weiguang Zeng, Andrea Stutz, Eicke Latz, Lorena E. Brown, Ashley S. Mansell · 2013 · PLoS Pathogens
  47. Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
    Mieke De Buck, Mieke Gouwy, Ji Wang, Jacques Van Snick, Ghislain Opdenakker, Sofie Struyf, Jo Van Damme · 2016 · Current Medicinal Chemistry
  48. TLR2/MyD88/NF-κB Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection
    Jesus A. Segovia, Ahmed Sabbah, Victoria E. Mgbemena, Su-Yu Tsai, Te-Hung Chang, Michael T. Berton, Ian R. Morris, Irving C. Allen, Jenny P.‐Y. Ting, Santanu Bose · 2012 · PLoS ONE
  49. Loop Between NLRP3 Inflammasome and Reactive Oxygen Species
    Abishai Dominic, Nhat-Tu Le, Masafumi Takahashi · 2021 · Antioxidants and Redox Signaling
  50. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications
    Chun Zeng, Xiaoyun Shi, Baojun Zhang, He Liu, Lianjun Zhang, Wenjun Ding, Yong Xiang Zhao · 2011 · Journal of Molecular Medicine
  51. Inflammasome Priming in Sterile Inflammatory Disease
    Patel, Meghana N., Carroll, Richard G., Galván-Peña, Silvia, Mills, Evanna L., Olden, Robin, Triantafilou, Martha, Wolf, Amaya I., Bryant, Clare E., Triantafilou, Kathy, Masters, Seth L. · 2017 · Trends in Molecular Medicine
  52. Serum Amyloid A Activates the NLRP3 Inflammasome and Promotes Th17 Allergic Asthma in Mice
    Jennifer L. Ather, Karina Ckless, Rebecca Martin, Kathryn L. Foley, Benjamin T. Suratt, Jonathan E. Boyson, Katherine A. Fitzgerald, Richard Anthony Flavell, Stephanie C. Eisenbarth, Matthew E. Poynter · 2011 · The Journal of Immunology
  53. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
    Moon, Jong-Seok, Lee, Seonmin, Park, Mi-Ae, Siempos, Ilias I., Haslip, Maria, Lee, Patty J., Yun, Mijin, Kim, Chun K., Howrylak, Judie, Ryter, Stefan W. et al. · 2015 · Journal of Clinical Investigation · Retracted
  54. Neutrophil-derived IL-1β Is Sufficient for Abscess Formation in Immunity against Staphylococcus aureus in Mice
    John S. Cho, Yi Guo, Romela Irene Ramos, Frank Hebroni, Seema B. Plaisier, Caiyun Xuan, Jennifer L. Granick, Hironori Matsushima, Akira Takashima, Yoichiro Iwakura et al. · 2012 · PLoS Pathogens
  55. Natural history of β-cell adaptation and failure in type 2 diabetes
    Emilyn U. Alejandro, Brigid Ellen Gregg, Manuel Blandino-Rosano, CORENTIN M.H. CRAS-MÉNEUR, Ernesto Bernal‐Mizrachi · 2014 · Molecular Aspects of Medicine
  56. Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation
    Chuang Wang, Ying Pan, Qing-Yu Zhang, Fu‐Meng Wang, Ling‐Dong Kong · 2012 · PLoS ONE
  57. SUMO-mediated regulation of NLRP3 modulates inflammasome activity
    Rachael E Barry, Sidonie Wicky John, Gianmaria Liccardi, Tencho Tenev, Isabel Jaco, Chih‐Hong Chen, Justin Chin-Bong Choi, Paulina Kasperkiewicz, Teresa Fernandes‐Alnemri, Emad S. Alnemri et al. · 2018 · Nature Communications
  58. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments
    Moritz Haneklaus, Luke A.J. O'Neill, Rebecca C. Coll · 2013 · Current Opinion in Immunology
  59. Inflammasomes as therapeutic targets in human diseases
    Yangxin Li, Hui Huang, Bin Liu, Yu Long Zhang, Xiangbin Pan, Xiyong Yu, Zhenya Shen, Yao‐Hua Song · 2021 · Signal Transduction and Targeted Therapy
  60. Fatty Acids and NLRP3 Inflammasome–Mediated Inflammation in Metabolic Tissues
    Jessica C. Ralston, Claire L. Lyons, Elaine B. Kennedy, Anna M. Kirwan, Helen M. Roche · 2017 · Annual Review of Nutrition
  61. Resident Macrophages Mediate Islet Amyloid Polypeptide–Induced Islet IL-1β Production and β-Cell Dysfunction
    Clara Y. Westwell-Roper, Jan A. Ehses, C. Bruce Verchere · 2013 · Diabetes
  62. β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
    Philippe A. Halban, Kenneth S. Polonsky, Donald W. Bowden, Meredith A. Hawkins, Charlotte Ling, Kieren J. Mather, Alvin C. Powers, Christopher J. Rhodes, Lori Sussel, Gordon C. Weir · 2014 · The Journal of Clinical Endocrinology & Metabolism
  63. Innate and adaptive immune responses to cell death
    Kenneth L. Rock, Jiann‐Jyh Lai, Hajime Kono · 2011 · Immunological Reviews
  64. The role of the NLRP3 inflammasome in gout
    Michael McDermott, Sarah R. Kingsbury, Philip G. Conaghan · 2011 · Journal of Inflammation Research
  65. Nutrient regulation of insulin secretion and action
    Philip Newsholme, Vínicius Fernandes Cruzat, Frank Arfuso, Kevin Noel Keane · 2014 · Journal of Endocrinology
  66. NLRP3 activation induced by neutrophil extracellular traps sustains inflammatory response in the diabetic wound
    Dan Liu, Peilang Yang, Min Gao, Tianyi Yu, Yan Shi, Meng Zhang, Min Yao, Yan Liu, Xiong Zhang · 2019 · Clinical Science
  67. Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
    Arpeeta Sharma, Mitchel Tate, Geetha Mathew, James Edward Vince, Rebecca Helen Ritchie, Judy B. de Haan · 2018 · Frontiers in Physiology
  68. COVID-19 Mobile Apps: A Systematic Review of the Literature
    Haridimos Kondylakis, Dimitrios G. Katehakis, Angelina Kouroubali, Fokion Logothetidis, Andreas K. Triantafyllidis, Ilias Kalamaras, Konstantinos Votis, Dimitrios K. Tzovaras · 2020 · Journal of Medical Internet Research
  69. Modification of Proteins by Metabolites in Immunity
    Ciana Diskin, Tristram A.J. Ryan, Luke A.J. O'Neill · 2020 · Immunity
  70. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis
    Pragnesh Mistry, Mariana J. Kaplan · 2016 · Clinical Immunology
  71. Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
    Carolina Pellegrini, Luca Antonioli, Gloria López‐Castejón, Corrado Blandizzi, Matteo Fornai · 2017 · Frontiers in Immunology
  72. The NLR family of innate immune and cell death sensors
    Balamurugan Sundaram, Rebecca E. Tweedell, Sivakumar Prasanth Kumar, Thirumala‐Devi Kanneganti · 2024 · Immunity
  73. RNA modifications by oxidation: A novel disease mechanism?
    Henrik Enghusen Poulsen, E Specht, Kasper Broedbaek, Trine Henriksen, Christina Ellervik, Thomas R Mandrup-Poulsen, Morten Tonnesen, Peter Eigil Nielsen, Henrik Ullits Andersen, Allan Weimann · 2012 · Free Radical Biology and Medicine
  74. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research
    Cunningham, Colm, Hennessy, Edel · 2015 · Alzheimer's Research & Therapy
  75. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation
    Hiroe Honda, Yoshinori Nagai, Takayuki Matsunaga, Naoki Okamoto, Yasuharu Watanabe, Koichi Tsuneyama, Hiroaki Hayashi, Isao Fujii, Masashi Ikutani, Yoshikatsu Hirai et al. · 2014 · Journal of Leukocyte Biology
  76. Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
    Nadine Gehrke, Jörn Markus Schattenberg · 2020 · Gastroenterology
  77. Islet inflammation in type 2 diabetes
    Marianne Böni‐Schnetzler, Daniel T. Meier · 2019 · Seminars in Immunopathology
  78. Metabolic Remodeling, Inflammasome Activation, and Pyroptosis in Macrophages Stimulated by Porphyromonas gingivalis and Its Outer Membrane Vesicles
    Andrew J. Fleetwood, Man K.S. Lee, William Singleton, Adrian A. Achuthan, Ming-Chin Lee, Neil Martin O’brien-simpson, Andrew D. Cook, Andrew James Murphy, Stuart G. Dashper, Eric Charles Reynolds et al. · 2017 · Frontiers in Cellular and Infection Microbiology
  79. NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials
    Bingbing Sun, Xiang Wang, Zhaoxia Ji, Ruibin Li, Tian Xia · 2012 · Small
  80. Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance
    Je‐Wook Yu, Myung‐Shik Lee · 2016 · Archives of Pharmacal Research
  81. The Role of Inflammation in β-cell Dedifferentiation
    Thierry M. Nordmann, Erez Dror, Friederike Schulze, Shuyang Traub, Ekaterine Berishvili, Charlotte Barbieux, Marianne Böni‐Schnetzler, Marc Yves Donath · 2017 · Scientific Reports
  82. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications
    Cernea, Simona, Dobreanu, Minodora · 2013 · Biochemia Medica
  83. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
    Ryan W. Grant, Vishwa Deep Dixit · 2013 · Frontiers in Immunology
  84. NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: A bipartisan affair?
    Bordt, Evan A., Polster, Brian M. · 2014 · Free Radical Biology and Medicine
  85. NOD-like receptors and the innate immune system: Coping with danger, damage and death
    Kristof Kersse, Mathieu J.M. Bertrand, Mohamed Lamkanfi, Peter Vandenabeele · 2011 · Cytokine & Growth Factor Reviews
  86. Mechanisms of islet amyloidosis toxicity in type 2 diabetes
    Andisheh Abedini, Ann Marie Schmidt · 2013 · FEBS Letters
  87. TXNIP Links Innate Host Defense Mechanisms to Oxidative Stress and Inflammation in Retinal Muller Glia under Chronic Hyperglycemia: Implications for Diabetic Retinopathy
    Takhellambam Swornalata Devi, Icksoo Lee, Maik Hüttemann, Ashok Kumar, Kwaku D. Nantwi, Lalit Pukhrambam Singh · 2012 · Experimental Diabetes Research
  88. NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
    Masafumi Takahashi · 2014 · International Heart Journal
  89. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
    Allison K. Meyers, Xuewei Zhu · 2020 · Cells
  90. NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury
    Savage, Catherine Diane, Lopez-Castejon, Gloria, Denes, Adam, Brough, David · 2012 · Frontiers in Immunology
  91. Innate sensors of pathogen and stress: Linking inflammation to obesity
    Chengcheng Jin, Richard Anthony Flavell · 2013 · Journal of Allergy and Clinical Immunology
  92. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
    Kehong Chen, Jian‐Guo Zhang, Weiwei Zhang, Jinhua Zhang, Jurong Yang, Kailong Li, Yani He · 2013 · The International Journal of Biochemistry & Cell Biology
  93. AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System
    Jingyue Jia, Bhawana Bissa, Lukas Brecht, Lee Allers, Seong Won Choi, Yuexi Gu, Mark Zbinden, Mark R. Burge, Graham S. Timmins, Kenneth R. Hallows et al. · 2020 · Molecular Cell
  94. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
    Isis Ludwig‐Portugall, Eva Bartok, Ermanila Dhana, Beatrix D.G. Evers, Michael J. Primiano, J. Perry Hall, Bernardo S. Franklin, Percy Alexander Knolle, Veit Hornung, Gunther Hartmann et al. · 2016 · Kidney International
  95. NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
    Fei Yan Zheng, Shan‐Shan Xing, Zushun Gong, Qichong Xing · 2013 · Heart Lung and Circulation
  96. IL-1 Blockade Attenuates Islet Amyloid Polypeptide-Induced Proinflammatory Cytokine Release and Pancreatic Islet Graft Dysfunction
    Clara Y. Westwell-Roper, Derek L. Dai, Galina Soukhatcheva, Kathryn J. Potter, Nico van Rooijen, Jan A. Ehses, C. Bruce Verchere · 2011 · The Journal of Immunology
  97. Innate Immune Receptors: Key Regulators of Metabolic Disease Progression
    Chengcheng Jin, Jorge Henao‐Mejia, Richard Anthony Flavell · 2013 · Cell Metabolism
  98. Molecular mechanisms of inflammasome signaling
    Anukriti Mathur, Jenni A. Hayward, Si Ming Man · 2017 · Journal of Leukocyte Biology
  99. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
    Chengfu Xu, Xingyong Wan, Lei Xu, Honglei Weng, Ming Yan, Min Miao, Yan Sun, Gen-Yun Xu, Steven Dooley, Youming Li et al. · 2015 · Journal of Hepatology
  100. Targeting inflammation in diabetes: Newer therapeutic options
    Neeraj Kumar Agrawal · 2014 · World Journal of Diabetes